Vijaya Diagnostic Centre Limited has intimated the National Stock Exchange of India Limited and BSE Limited about an upcoming Board of Directors meeting scheduled for Tuesday, November 3, 2026.
The primary agenda items for the board meeting include:
- Consideration and approval of the standalone unaudited financial results for the quarter and half year ended September 30, 2026
- Consideration and approval of the consolidated unaudited financial results for the quarter and half year ended September 30, 2026
- Discussion of other corporate matters
The disclosure is made pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company had previously communicated on September 28, 2026 about the closure of the trading window for dealing in the company's securities. The trading window remains closed for all designated persons and their immediate relatives from October 1, 2026, and will continue to remain closed until 48 hours after the announcement of financial results, specifically until November 5, 2026 (both days inclusive).